Performance of AKBA Akebia Ther | 8.3% in 12m
Compare AKBA with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Akebia Ther with its related Sector/Index XBI
Performance Duell AKBA vs XBI
| TimeFrame | AKBA | XBI |
|---|---|---|
| 1 Day | -4.07% | 2.02% |
| 1 Week | -15.7% | 3.93% |
| 1 Month | -15.1% | 7.25% |
| 3 Months | -19.7% | -0.71% |
| 6 Months | 18.0% | 30.27% |
| 12 Months | 8.26% | 5.80% |
| YTD | -7.09% | 2.64% |
| Rel. Perf. 1m | -2.05 | |
| Rel. Perf. 3m | -0.43 | |
| Rel. Perf. 6m | -0.24 | |
| Rel. Perf. 12m | 0.65 |
Is Akebia Ther a good stock to buy?
No, based on ValueRay Fundamental Analyses, Akebia Ther (NASDAQ:AKBA) is currently (May 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -80.90 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AKBA as of May 2024 is 1.11. This means that AKBA is currently overvalued and has a potential downside of -5.93% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AKBA as of May 2024 is 1.11. This means that AKBA is currently overvalued and has a potential downside of -5.93% (Sold with Premium).
Is AKBA a buy, sell or hold?
- Strong Buy: 1
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
Values above 0%: AKBA is performing better - Values below 0%: AKBA is underperforming
Compare AKBA with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -18.14% | -20.13% | -0.66% | -21.87% |
| US NASDAQ 100 | QQQ | -18.63% | -20.18% | 0.10% | -31.26% |
| US Dow Jones Industrial 30 | DIA | -17.96% | -21.04% | 2.94% | -13.68% |
| German DAX 40 | DBXD | -17.69% | -19.60% | -1.45% | -9.86% |
| UK FTSE 100 | ISFU | -18.27% | -23.22% | 1.14% | -5.73% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -16.23% | -18.79% | 17.13% | 19.36% |
| Hongkong Hang Seng | HSI | -21.51% | -33.44% | 16.67% | 18.14% |
| Japan Nikkei 225 | EXX7 | -15.64% | -10.90% | 5.93% | -5.31% |
| India NIFTY 50 | INDA | -16.31% | -17.20% | 1.56% | -17.59% |
| Brasil Bovespa | EWZ | -13.33% | -17.77% | 20.53% | -3.05% |
AKBA Akebia Ther vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -17.27% | -17.89% | -0.90% | -30.59% |
| Consumer Discretionary | XLY | -16.33% | -17.86% | 10.90% | -13.58% |
| Consumer Staples | XLP | -16.73% | -20.88% | 6.63% | 4.84% |
| Energy | XLE | -16.58% | -13.72% | 5.02% | -14.85% |
| Financial | XLF | -17.69% | -20.93% | -4.65% | -25.24% |
| Health Care | XLV | -18.61% | -20.57% | 2.82% | -4.35% |
| Industrial | XLI | -16.99% | -18.32% | -3.06% | -21.14% |
| Materials | XLB | -17.15% | -17.95% | 1.57% | -10.99% |
| Real Estate | XLRE | -20.46% | -21.23% | 8.31% | -0.37% |
| Technology | XLK | -19.71% | -20.82% | 0.67% | -32.85% |
| Utilities | XLU | -18.93% | -29.13% | -1.47% | -1.81% |
| Aerospace & Defense | XAR | -16.98% | -23.11% | 3.52% | -17.82% |
| Biotech | XBI | -19.64% | -22.36% | -12.27% | 2.46% |
| Homebuilder | XHB | -20.05% | -22.03% | -17.34% | -47.11% |
| Retail | XRT | -21.18% | -24.34% | -4.40% | -19.98% |
Does Akebia Ther outperform its market, is AKBA a Sector Leader?
Yes, over the last 12 months Akebia Ther (AKBA) made 8.26%, while its related Sector, the SPDR S&P Biotech (XBI) made 5.80%.
Over the last 3 months AKBA made -19.73%, while XBI made -0.71%.
Yes, over the last 12 months Akebia Ther (AKBA) made 8.26%, while its related Sector, the SPDR S&P Biotech (XBI) made 5.80%.
Over the last 3 months AKBA made -19.73%, while XBI made -0.71%.
| Period | AKBA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -15.11% | 7.25% | 5.02% |
| 3 Months | -19.73% | -0.71% | 5.86% |
| 12 Months | 8.26% | 5.80% | 30.13% |